Cycle 2 – Module 8 – Lecture 7 – Slimming appetite-reducing hormone therapies: GLP-1 and HCG (1h23)

Content is one video of 1h23, a PDF presentation file, and PDF references on:

• Two major types of hormone therapies reduce appetite
  • Glucagon-like peptide 1 analogues
  • HCG
• A review of different types of glucagon-like peptide 1 analogues with their pros and cons: liraglutide, semaglutide, tirzepatide, etc.
• Indications, dosing, frequency, side effects, overdoses of glucagon-like peptide 1 analogues
• HCG cures: history, doses, route of administration, duration, timing of repeats, conditions to success, trials
• Mechanisms by which these hormone therapies reduce appetite and obtain weight loss
• The scientific studies
• Practical tips and doses
• Attractive and informative pictures together with practical tips make of this a fascinating video session
• Among the scientific data provided include:
  • A list of references of scientific studies showing associations between low GLP-1 levels and increased appetite
  • A list of references of trials where these treatments reduced or increased the appetite and promoted weight loss

 

Abstract:

This video lecture offers all the necessary information to obtain weight loss with a low-calorie diet and the administration of appetite-reducing hormones, such as glucagon-like peptide 1 analogues and the historical HCG.

To reduce the appetite, an efficient treatment is to prescribe the patient a glucagon-like peptide 1 analogue, which reduces appetite by various mechanisms that are discussed in this lecture. Depending on the type of analogue, administration occurs daily or weekly.

Indications and contra-indications, how to settle side effects, doses, efficacy of various types of glucagon-like peptide 1 analogues are compared one to another, particularly of liraglutide, semaglutide, and tirzepatide are presented in this lecture.

Abundant information is provided on human gonadotropin (HCG) treatment, which dates back to the 1960s under the impulse of the British doctor Simons. This treatment is presented as a treatment that can reverse all types of obesity, but in particular, overweight due to a diencephalon deficiency. What this is and how typical fat deposits accumulate all over the body in diencephalon deficiency can be reduced by this treatment, which is done in cures. Of particular interest are the pictures showing physical signs of diencephalon deficiency. Many tips on how to make an HCG cure a success are provided in this lecture. The advantages of an HCG cure lie also in its transient character (it is a cure) but with relatively permanent effects, which can also make the body firmer (improved body composition, tighter skin) besides making it lighter.

This session is illustrated with many pictures and scientific references.

 

Educational outcome:

To transmit knowledge on two efficient hormone therapies that reduce weight by reducing appetite.

 

Learning outcomes:

The physician learns

1. Which overweight and obese patients may respond well to glucagon-like peptide 1 analogues and which obese patients are candidates for HCG treatment
2. How to differentiate clinically (symptomatically) obese patients with diencephalon deficiency
3. How to treat overweight patients with various glucagon-like peptide 1 analogues and adjust doses and type of GLP-1 analogue to the patients
4. How to treat obese, even massively obese, patients with HCG cures until a slim body is achieved

More about scientific studies that support this information, including double-blind placebo-controlled trials.